Loading...

Optimising infliximab induction dosing for patients with ulcerative colitis

AIMS: The therapeutic failure of infliximab therapy in patients with ulcerative colitis remains a challenge even 2 decades after its approval. Therapeutic drug monitoring (TDM) has shown value during maintenance therapy, but induction therapy has still not been explored. Patients may be primary nonr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Clin Pharmacol
Main Authors: Dreesen, Erwin, Faelens, Ruben, Van Assche, Gert, Ferrante, Marc, Vermeire, Séverine, Gils, Ann, Bouillon, Thomas
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422726/
https://ncbi.nlm.nih.gov/pubmed/30634202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13859
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!